Compare Abbott India with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs NOVARTIS - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA NOVARTIS ABBOTT INDIA/
NOVARTIS
 
P/E (TTM) x 49.0 1,943.4 2.5% View Chart
P/BV x 15.8 25.8 61.4% View Chart
Dividend Yield % 0.4 1.7 25.4%  

Financials

 ABBOTT INDIA   NOVARTIS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
NOVARTIS
Mar-19
ABBOTT INDIA/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs8,834980 901.4%   
Low Rs5,458600 909.3%   
Sales per share (Unadj.) Rs1,731.1198.7 871.1%  
Earnings per share (Unadj.) Rs211.921.0 1,010.7%  
Cash flow per share (Unadj.) Rs219.922.3 988.0%  
Dividends per share (Unadj.) Rs65.0010.00 650.0%  
Dividend yield (eoy) %0.91.3 71.9%  
Book value per share (Unadj.) Rs945.2307.5 307.4%  
Shares outstanding (eoy) m21.2524.69 86.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.0 103.8%   
Avg P/E ratio x33.737.7 89.5%  
P/CF ratio (eoy) x32.535.5 91.5%  
Price / Book Value ratio x7.62.6 294.2%  
Dividend payout %30.747.7 64.3%   
Avg Mkt Cap Rs m151,84819,508 778.4%   
No. of employees `0003.50.6 599.8%   
Total wages/salary Rs m4,3561,171 371.9%   
Avg. sales/employee Rs Th10,555.58,445.4 125.0%   
Avg. wages/employee Rs Th1,249.92,015.7 62.0%   
Avg. net profit/employee Rs Th1,292.2891.0 145.0%   
INCOME DATA
Net Sales Rs m36,7864,907 749.7%  
Other income Rs m1,133783 144.8%   
Total revenues Rs m37,9195,689 666.5%   
Gross profit Rs m6,047123 4,924.5%  
Depreciation Rs m16932 532.1%   
Interest Rs m2316 141.5%   
Profit before tax Rs m6,989858 814.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485340 730.9%   
Profit after tax Rs m4,503518 869.9%  
Gross profit margin %16.42.5 656.9%  
Effective tax rate %35.639.6 89.7%   
Net profit margin %12.210.6 116.0%  
BALANCE SHEET DATA
Current assets Rs m27,6108,055 342.8%   
Current liabilities Rs m8,5691,850 463.2%   
Net working cap to sales %51.8126.4 40.9%  
Current ratio x3.24.4 74.0%  
Inventory Days Days6045 133.8%  
Debtors Days Days2734 80.8%  
Net fixed assets Rs m1,057150 705.5%   
Share capital Rs m213123 172.2%   
"Free" reserves Rs m19,8737,469 266.1%   
Net worth Rs m20,0867,592 264.6%   
Long term debt Rs m00-   
Total assets Rs m29,4099,824 299.3%  
Interest coverage x311.654.9 567.1%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.5 250.4%   
Return on assets %15.45.4 283.3%  
Return on equity %22.46.8 328.8%  
Return on capital %34.911.5 303.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36958 640.6%   
Fx outflow Rs m4,9181,326 370.8%   
Net fx Rs m-4,549-1,269 358.6%   
CASH FLOW
From Operations Rs m4,991-1,943 -256.9%  
From Investments Rs m-2,5702,742 -93.7%  
From Financial Activity Rs m-1,428-298 478.9%  
Net Cashflow Rs m993501 198.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 7.9 2.0 395.0%  
FIIs % 0.1 1.6 6.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 21.5 79.5%  
Shareholders   18,270 41,647 43.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   JUBILANT PHARMOVA   PANACEA BIOTECH  WOCKHARDT  GSK PHARMA  FRESENIUS KABI ONCO.  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS